Just diagnosed? Learn more.

A kidney cancer diagnosis can be scary and confusing. You're not alone. KidneyCAN has put together resources to help you navigate a new diagnosis, your treatment options, and living well with cancer.

We Did It!

Thanks to the hard work of many advocates in the kidney cancer community, Congress has allocated $50 million in federal funding for research in 2021. Learn how our team worked for this!

Kidney Cancer Research Summit 2021

Registration is open for the 2021 Kidney Cancer Research Summit. We are also accepting abstracts for original research in translational and basic science, clinical research, and trials in progress.

Making Progress Toward Cures

Our Goals

  • We provide education, resources, and support to kidney cancer patients and caregivers
  • We identify patients’ and researchers’ unmet needs
  • We engage and educate policymakers on the urgency of kidney cancer research funding
  • We urge Congress to fund kidney cancer research
  • We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
  • We provide direct funding to promising ideas
  • We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
  • We grow the community of kidney cancer researchers
  • We support the development of new treatments by educating patients on trial access and enrollment
  • We identify new unmet needs, set new goals, and keep working

Our Mission

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

NEWLY DIAGNOSED?

You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.  

BUILD A CARE TEAM

One of the best decisions you can make when facing kidney cancer is to choose an experienced medical team. We’ve put together resources including a checklist of questions for your doctor and a list of NCI comprehensive cancer centers.

For Patients

Advocacy

Research

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

#ESMO21 : QoL is one of the main pillars that should always be kept in mind in the treatment of patients with mRCC!! @myESMO @OncoAlert @AlbigesL
@kidneycan @KidneyCancer @urotoday

#ESMO21 @myESMO GU proffered session Lively question/answer session & discussion led by @AlbigesL , @brian_rini 👉 maintaining patients QOL , a fundamental goal in oncology, + intermittent ...TKI/dose modification may be used in selected patients with #kidneycancer @OncoAlert

Please take a moment to answer this poll from @SoaresAndrey - @kidneycan @KidneyCancer @KCA_Journal https://t.co/NFE46gAslk

After STAR trial results would you consider to recommend treatment interval strategy for patients receiving TKI in 2L after IO based therapy in 1L? Please RT @montypal @drenriquegrande @tompowles1 @cdanicas @brian_rini @TiansterZhang @ERPlimackMD @motzermd @DrChoueiri @AlbigesL

#ESMO21 @myESMO Keynote-564 trial 👉 adjuvant pembrolizumab significantly delay #kidneycancer disease recurrence without compromising patient reported quality of like + physical function ...@DrChoueiri @OncoAlert @kidneycan @tompowles1

Inspiring mood! Resilience. Flipping the switch. Tackling the next next.
🧡💚

I’m resilient. Spent the morning in meltdown, then flipped the switch.

I had a great time at PT, kicked ass.

Looked at my scans again. It could be worse.

Back in the saddle at work too and ready to figure out the next next for my kidney cancer.

Being presented by Dr. Andy Hahn at #ESMO21, a recent study suggests cytoreductive nephrectomy should be considered in patients with certain types of renal cell carcinoma treated with immune ...checkpoint inhibitors: https://t.co/PEMVPxRHzr. #EndCancer https://t.co/aogP46FtTb

Looking forward to #ESMO21 @myESMO. Check out our poster on cytoreductive nephrectomy in met sarcomatoid and/or rhabdoid RCC who receive ICI. Mentored by @PavlosMsaouel @MDAndersonNews

Can’t think of a more deserving individual! Bringing people together across the globe with the mission to improve cancer outcomes for all patients. @DrChoueiri congrats! https://t.co/XlRxemLcRQ

Dear friends

An Amazing way to start #ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your @OncoAlert network @DrChoueiri who has just been named a GIANT of #Cancer care @GiantsofCC @GCCAwards

We are SO PROUD & congratulate him on this well deserved award!

From those of us who have known you as a GIANT in this field for years already to those just learning today with the announcement of this award, may I say this is SO well deserved. May you never lose... your drive and passion for improving the lives of your patients, @DrChoueiri! https://t.co/kmpltahXl9

Dear friends

An Amazing way to start #ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your @OncoAlert network @DrChoueiri who has just been named a GIANT of #Cancer care @GiantsofCC @GCCAwards

We are SO PROUD & congratulate him on this well deserved award!

When we formed KidneyCAN in 2016, the amount of money Congress allocated specifically for kidney cancer research was $0. Through advocacy, we’ve generated $135 million in research funding in five years.

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter...

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for...

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year...

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher...

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community. 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...